MVP1 (Major Vault Protein 1), also known as LRP (Lung Resistance Protein), is a 110 kDa structural component of vault complexes—large ribonucleoprotein particles involved in nucleo-cytoplasmic transport, chemoresistance, and signaling regulation . MVP1 is overexpressed in multidrug-resistant cancers, including papillary thyroid cancer (PTC), breast, liver, and colon cancers, where it correlates with poor prognosis . Antibodies targeting MVP1 are critical tools for studying its role in oncogenesis, immune modulation, and therapeutic resistance.
MVP1 antibodies are utilized in diverse experimental workflows:
| Application | Method | Key Antibodies | Reactivity |
|---|---|---|---|
| Western Blot (WB) | Protein detection | Abcam ab97311, Proteintech 16478-1-AP | Human, Mouse, Rat |
| Immunohistochemistry (IHC) | Tissue localization | ab97311, 16478-1-AP | Human, Mouse |
| Immunofluorescence (ICC/IF) | Cellular localization | ab97311, 16478-1-AP | Human, Mouse |
| Immunoprecipitation (IP) | Protein interaction studies | 16478-1-AP | Human, Mouse |
Notable Antibodies:
Abcam ab97311: Rabbit polyclonal antibody validated in WB, IHC, and ICC/IF for human/mouse samples, with a predicted band size of 99 kDa .
Proteintech 16478-1-AP: Rabbit polyclonal antibody reactive with human, mouse, and rat samples, tested in WB, IHC, IF, and IP .
MVP1’s role in cancer progression and immune modulation has been extensively studied:
Clinical Implications:
MVP1 serves as a biomarker for chemoresistance and immune evasion. Its overexpression in cancers like PTC is linked to BRAF V600E mutations, suggesting therapeutic targeting potential .
MVP1’s oncogenic roles are mediated through:
Pathway Activation: Enhances PI3K/AKT/mTOR and MAPK/ERK signaling, driving proliferation and survival .
Endosomal Recycling: In yeast, MVP1 (Mvp1) deforms endosomal membranes and recruits Vps1 (dynamin-like GTPase) to scission recycling tubules, a process conserved in humans via SNX8 .
Immune Microenvironment Modulation: High MVP1 expression correlates with increased CD8+ T cell infiltration but poor clinical outcomes, indicating complex immune regulation .